Although some Authors stress to perform PTG also in germline CDH1 pathogenic mutation carriers with unclear family history for GC,30 PTG should be considered only in case of a clear HDGC phenotype with a documented germline CDH1 pathogenic variant. This evidence concerns the gene CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome.